340B Hospital Commitment to Good Stewardship Principles

In its more than 25-year history, the 340B Drug Pricing Program has been critical in helping hospitals expand access to lifesaving prescription drugs and comprehensive health care services in vulnerable communities across the country, including to low-income and uninsured individuals. 340B hospitals support transparency to ensure that the program meets the Congressional objective: “to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example reaching more eligible patients and providing more comprehensive services for those in the community.

The following principles serve as the foundation for every 340B hospitals’ good stewardship of the program. To align with this “Commitment to Good Stewardship Principles,” 340B hospitals would:

  • Communicate the Value of the 340B Program: The hospital commits to preparing and publishing a narrative, on an annual basis, that describes how it uses 340B savings to benefit its community. The narrative would address those programs and services funded, in whole or in part, by 340B savings, including those services that support community access to care that the hospital could not continue without 340B savings. Examples of such programs and services will be particular for each hospital and could include programs that expand access to drugs for vulnerable populations, as well as access to a wide range of other services, such as preventive care, emergency services, cancer treatment, vaccinations, home-based care, and mental and behavioral health services.
  • Disclose Hospital’s 340B Estimated Savings: The hospital commits to publicly disclosing, on an annual basis, its 340B estimated savings calculated using a standardized method. That method would calculate 340B savings by comparing the 340B acquisition price to group purchasing organization pricing. If GPO pricing is not available for a 340B drug, the 340B acquisition price for a drug would be compared to another acceptable pricing source. To provide context for the estimated savings, a hospital could compare its 340B estimated savings to the hospital’s total drug expenditures, as well as provide examples of its top 340B drugs.
  • Continue Rigorous Internal Oversight: The hospital commits to continuing to conduct internal reviews to ensure that the hospital 340B program meets the Health Resources and Services Administration’s program rules and guidance. Included in this effort is a commitment to regular and periodic training for the hospital’s interdisciplinary 340B teams that encompass C-Suite executives, pharmacy, legal, and financial assistance, as well as community outreach and government relations staff, if applicable.

Examples of Hospitals and Health Systems Telling Their 340B Story

AHA’s 340B Webinar on the Good Stewardship Principles

The AHA 340B Advocacy Alliance hosted a special webinar on June 5. We heard from senior representatives from Johns Hopkins Medicine, Providence St. Joseph Health and the University of California who shared their firsthand experiences implementing the AHA's 340B Good Stewardship Principles within their organizations.
June 5, 2019

Listen to the recording of the webinar.

Download the PowerPoint slides for the webinar.

Hospitals Share Examples of How They Are Sharing Value of 340B Program

UCLA Health and UC Davis Health in California – both organizations that have committed to the 340B Good Stewardship Principles – have shared examples of how they are communicating the value of the 340B program. Click below to view each of the organization’s webpage with information on how they use their estimated 340B savings to improve their communities access to health care services.

UC San Diego Health

Testimony for House Committee on Energy and Commerce 340B Oversight Hearing
July 11, 2018

The Johns Hopkins Hospital

Testimony for House Committee on Energy and Commerce Subcommittee on Oversight and Investigations
October 11, 2017